Cite this: Assessment of the Acceptability of a New Salbutamol Multidose Dry Powder Inhaler (DPI) in Patients with Asthma - Medscape - Mar 01, 2000.

GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...

Read about Glaxosmithkline Pharmaceuticals Ltd company details like share price, management, news and more at IIFL Capital.

Researchers at Fraunhofer ITEM have shown for the first time that drug levels in the lung can be measured directly using particles in exhaled breath. For this breakthrough, Prof. Jens Hohlfeld and Dr.

Asthma treatment in the UK has until recently relied heavily on a strategy of regular ‘maintenance’ inhaled corticosteroid (ICS) and separate ‘reliever’ inhalers containing short-acting beta-agonist ...

Objective The β2-agonists such as salbutamol are the mainstay of asthma management. Pharmacokinetic–pharmacodynamic (PKPD) models to guide paediatric dosing are lacking. We explored the relationship ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Those patients who required longer treatment with nebulised bronchodilators could continue with salbutamol, with or without ipratropium, and any patients who were judged to have improved sufficiently ...

Background Inhaled corticosteroid (ICS) use could decrease local immunity of the lung. Concerns have been raised regarding the risk of tuberculosis (TB) development among ICS users. The aim of this ...

Objective Overuse of short-acting bronchodilators is internationally recognised as a marker of poor asthma control, high healthcare use and increased risk of asthma death. Young adults with asthma ...

U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for children.